What Factors Propelled The Growth Of The Digital Biomanufacturing Market In The Past?
The digital biomanufacturing market has seen considerable growth due to a variety of factors.
• The size of the digital biomanufacturing market has expanded quickly in the recent past. This market is anticipated to inflate from $21.11 billion in 2024 to $23.82 billion in 2025, with a compound annual growth rate (CAGR) of 12.8%.
The growth witnessed in the historical period can be traced back to factors such as the escalating complexity of biopharmaceuticals, the surge in personalized medicine, the need for cost-effective production, the optimization of bioprocess, stringent quality control and compliance with regulations.
What Can Be Expected from the Digital Biomanufacturing Market in the Coming Years?
The digital biomanufacturing market is expected to maintain its strong growth trajectory in upcoming years.
• The digital biomanufacturing sector is predicted to experience significant expansion in the coming years. It is projected to reach $40.43 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.1%.
This growth during the forecast period can be ascribed to the use of blockchain for enhancing supply chain transparency, the employment of advanced process control (APC) systems, a focus on sustainability, the interconnection of biomanufacturing ecosystems, and the rise of biomanufacturing in developing markets. Key trends for the forecasted period encompass the incorporation of artificial intelligence (AI), the use of digital twins in bioprocessing, progress in biotechnology, the integration of Industry 4.0, along with real-time monitoring and control.
Which Drivers Are Accelerating Growth In The Digital Biomanufacturing Market?
The anticipated surge in demand for biologics is projected to boost expansion in the digital biomanufacturing market. This broad class of pharmaceuticals encompasses immunological modulators, vaccines, growth factors, human blood and plasma-derived drugs, and monoclonal antibodies. Digital biomanufacturing provides an effective way of boosting biologics production through process optimization, quality control enhancement, cost reduction, and reduced production duration. This allows manufacturers to employ data-centric strategies and state-of-the-art technologies to meet the escalating demand for biologics in a more sustainable and efficient manner. For instance, Cell & Gene, a US-based digital platform serving research scholars, reported in February 2023 that 27 FDA-approved cell and gene therapies (CGTs) existed, comprising about 8% of the 340 approved biologics the previous year. This marked an augmentation from the 22 approvals in 2021. Consequently, this rising demand for biologics is spearheading the growth in the digital biomanufacturing market.
How Are The Segments Defined Within The Global Digital Biomanufacturing Market?
The digital biomanufacturing market covered in this report is segmented –
1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing
Pre-Book The Digital Biomanufacturing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Digital Biomanufacturing Market?
Leading firms in the industry are consolidating their market positions by focusing on innovative approaches such as single-use bioprocessing systems. These systems enhance digital biomanufacturing by offering flexibility, real-time monitoring, lower contamination threats, and cost-effective solutions. For example, in October 2022, the Indian biotech startup, PharmNXT Biotech LLP, inaugurated its premier integrated manufacturing unit in Pune, aimed at offering single-use bioprocessing solutions. This sophisticated facility was established to overcome the obstacles associated with biologics production in India. This new establishment is expected to create job opportunities for around 100 to 200 individuals and will service demand from international markets such as Singapore, Korea, Europe, and the US. The Ekuse production unit will focus on creating the Xelta line of single-use bioprocessing products and the levitating mixing technology 'NXTmix'.
Who Are the Key Players in the Digital Biomanufacturing Market?
Major companies operating in the digital biomanufacturing market include:
• Sanofi SA
• Thermo Fisher Scientific Inc.
• Honeywell International Inc.
• 3M Company
• SAP SE
• Danaher Corporation
• ABB AG
• Siemens Healthineers AG
• Emerson Electric Co
• GE HealthCare Technologies Inc.
• Atos SE
• Agilent Technologies Inc.
• Cytiva Europe GmbH
• Lonza Group AG
• Dassault Systèmes SE
• Sartorius AG
• BioMérieux
• Donaldson Company Inc.
• Pall Corporation
• Eppendorf AG
• Symphony Innovation LLC
• Koch Membrane Systems Inc.
• Culture Biosciences Inc.
• Bota Biosciences Inc.
• Shimadzu Corporation
• e-MSion
• Exponential Genomics Inc.
• Immersciobio GmbH
What Is The Most Dominant Region In The Digital Biomanufacturing Market?
North America was the largest region in the digital biomanufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
